Ben E.E.M. van den Borne

2.9k total citations
29 papers, 977 citations indexed

About

Ben E.E.M. van den Borne is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ben E.E.M. van den Borne has authored 29 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 5 papers in Surgery. Recurrent topics in Ben E.E.M. van den Borne's work include Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Ben E.E.M. van den Borne is often cited by papers focused on Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Ben E.E.M. van den Borne collaborates with scholars based in Netherlands, United States and Italy. Ben E.E.M. van den Borne's co-authors include Lidwien Graat‐Verboom, Martijn A. Spruit, Emiel F.�M. Wouters, Frank W.J.M. Smeenk, Ragnar Lunde, Harry J.M. Groen, Bonne Biesma, J. J. Jakimowicz, André van Zundert and J.A.W. Wildsmith and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Respiratory Journal.

In The Last Decade

Ben E.E.M. van den Borne

27 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ben E.E.M. van den Borne Netherlands	16	529	247	206	190	128	29	977
Tessa M. van Ginhoven Netherlands	18	152 0.3×	178 0.7×	561 2.7×	114 0.6×	124 1.0×	76	1.2k
Eduardo A. Vega United States	18	286 0.5×	410 1.7×	416 2.0×	214 1.1×	64 0.5×	87	931
Alptekin Gürsoy Türkiye	23	140 0.3×	156 0.6×	446 2.2×	70 0.4×	138 1.1×	67	1.6k
Goce Spasovski North Macedonia	16	212 0.4×	104 0.4×	174 0.8×	100 0.5×	40 0.3×	108	1.1k
Luciano Colangelo Italy	18	96 0.2×	256 1.0×	229 1.1×	270 1.4×	81 0.6×	64	1.1k
Ashley L. Cole United States	18	350 0.7×	82 0.3×	154 0.7×	36 0.2×	252 2.0×	52	1.1k
Hazel R. Scott United Kingdom	9	282 0.5×	780 3.2×	246 1.2×	26 0.1×	213 1.7×	11	1.1k
Miranda J.M. Dirx Netherlands	14	423 0.8×	454 1.8×	188 0.9×	29 0.2×	182 1.4×	18	1.0k
Marloes T. Bazelier Netherlands	22	74 0.1×	320 1.3×	286 1.4×	244 1.3×	106 0.8×	44	1.4k
Soichiro Iimori Japan	16	90 0.2×	85 0.3×	70 0.3×	154 0.8×	91 0.7×	41	757

Countries citing papers authored by Ben E.E.M. van den Borne

Since Specialization

Citations

This map shows the geographic impact of Ben E.E.M. van den Borne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben E.E.M. van den Borne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben E.E.M. van den Borne more than expected).

Fields of papers citing papers by Ben E.E.M. van den Borne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben E.E.M. van den Borne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben E.E.M. van den Borne. The network helps show where Ben E.E.M. van den Borne may publish in the future.

Co-authorship network of co-authors of Ben E.E.M. van den Borne

This figure shows the co-authorship network connecting the top 25 collaborators of Ben E.E.M. van den Borne. A scholar is included among the top collaborators of Ben E.E.M. van den Borne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben E.E.M. van den Borne. Ben E.E.M. van den Borne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Degens, Juliette, et al.. (2025). Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC. JTO Clinical and Research Reports. 6(3). 100790–100790.

Heine, Rob ter, Bas Peters, Nienke A. G. Lankheet, et al.. (2025). The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study. Clinical Lung Cancer. 26(4). 324–330.e3.

Deenen, Maarten J., et al.. (2025). Opportunities for Precision Dosing of Cytotoxic Drugs in Non-Small Cell Lung Cancer: Bridging the Gap in Precision Medicine. Clinical Pharmacokinetics. 64(4). 511–531. 3 indexed citations

Deenen, Maarten J., Dirk Jan A. R. Moes, Jeroen J. M. A. Hendrikx, et al.. (2024). An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab. Targeted Oncology. 19(5). 779–787. 2 indexed citations

Brom, Linda, Arnold Baars, Jean‐Paul van Basten, et al.. (2024). Open communication between patients and relatives about illness & death in advanced cancer—results of the eQuiPe Study. Supportive Care in Cancer. 32(4). 214–214. 3 indexed citations

Belderbos, Huub, Gerben Stege, Luc Brunsveld, et al.. (2024). Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals. Lung Cancer. 189. 107477–107477. 2 indexed citations

Borne, Ben E.E.M. van den, Huub Belderbos, Gerben Stege, et al.. (2023). Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer. Lung Cancer. 178. 28–36. 21 indexed citations

Houterman, Saskia, et al.. (2022). The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer. Cancer Treatment and Research Communications. 34. 100676–100676. 2 indexed citations

Noort, Vincent van der, Joachim G.J.V. Aerts, Egbert F. Smit, et al.. (2022). Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI)versusintercalated TKI with chemotherapy forEGFR-mutated nonsmall cell lung cancer. ERJ Open Research. 8(4). 239–2022. 10 indexed citations

10.

Borne, Ben E.E.M. van den, et al.. (2018). Utilization of Molecular Testing and Survival Outcomes of Treatment with First- or Second-line Tyrosine Kinase Inhibitors in Advanced Non-small Cell Lung Cancer in a Dutch Population. Anticancer Research. 38(1). 393–400. 14 indexed citations

11.

Dingemans, Anne‐Marie C., Harry J.M. Groen, Gerarda J.M. Herder, et al.. (2015). A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170). Annals of Oncology. 26(11). 2286–2293. 30 indexed citations

12.

Louie, Alexander V., Erik van Werkhoven, Hanbo Chen, et al.. (2015). Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial. Radiotherapy and Oncology. 117(1). 44–48. 59 indexed citations

13.

Hendriks, Lizza, Esther G.C. Troost, Gerben Bootsma, et al.. (2014). Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases. Acta Oncologica. 53(7). 945–951. 14 indexed citations

14.

Swarts, Dorian R.A., Robert‐Jan van Suylen, Michael A. den Bakker, et al.. (2014). Interobserver Variability for the WHO Classification of Pulmonary Carcinoids. The American Journal of Surgical Pathology. 38(10). 1429–1436. 67 indexed citations

15.

Ponten, Jeroen E. H., et al.. (2012). Cardiac herniation after operative management of lung cancer: a rare and dangerous complication. General Thoracic and Cardiovascular Surgery. 60(10). 668–672. 9 indexed citations

16.

Graat‐Verboom, Lidwien, et al.. (2012). Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: A case control study. Bone. 50(6). 1234–1239. 45 indexed citations

17.

Graat‐Verboom, Lidwien, Martijn A. Spruit, Ben E.E.M. van den Borne, et al.. (2009). Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respiratory Medicine. 103(8). 1143–1151. 88 indexed citations

18.

Janssen‐Heijnen, M.L.G., V.E.P.P. Lemmens, Ben E.E.M. van den Borne, et al.. (2007). Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands. Critical Reviews in Oncology/Hematology. 62(2). 172–178. 34 indexed citations

19.

Beijer, Sandra, P. Hupperets, Ben E.E.M. van den Borne, et al.. (2007). Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients. Investigational New Drugs. 25(6). 571–579. 23 indexed citations

20.

Zundert, André van, et al.. (2006). Segmental spinal anaesthesia for cholecystectomy in a patient with severe lung disease. British Journal of Anaesthesia. 96(4). 464–466. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact